FDA
approval
· 2020-02-24
FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
Summary
The FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride (Actavis) related to its use for nausea and vomiting during pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)